This metabolite features a PDE selectivity profile comparable to sildenafil and an in vitro potency for PDE5 somewhere around 50% with the mother or father drug. Plasma concentrations of this metabolite are somewhere around 40% of All those found for sildenafil, so which the metabolite accounts for about twenty% of sildenafil's pharmacologic conseq